Compare drug alternatives
Ubrelvy® Alternatives
Ubrelvy®
(ubrogepant)
Ubrelvy
-
Migraine
- Emgality®
- Vyepti®
- Aimovig®
- Nurtec ODT®
- Qulipta®
Prescription Only
Ubrelvy is a medication that adults can use to treat acute migraine attacks. It works by blocking CGRP, a protein believed to contribute to migraine attacks by causing pain, blood vessel dilation, and inflammation. Ubrelvy is well-tolerated, with less than 5% of individuals reporting side effects such as nausea, somnolence, and dry mouth. Ubrelvy does not prevent migraines.
Ubrelvy is FDA approved for the following indications: Migraine.
Ajovy®
(Fremanezumab)
Ajovy
-
Migraine
- Emgality®
- Vyepti®
- Aimovig®
- Nurtec ODT®
- Qulipta®
Prescription Only
Ajovy is a prescription medication that can be self-injected once a month or once every three months under the skin to prevent migraine headaches. The most commonly reported side effect is injection site reactions. Ajovy does not seem to cause constipation. Additionally, there are no known drug interactions.
Ajovy is FDA approved for the following indications: Migraine prevention.
Dosage & Administration
Administration
Oral
Subcutaneous
Dosing
50 mg or 100 mg as needed. Maximum daily dose: 200 mg. Severe Hepatic or Severe Renal Impairment: 50 mg.
225 mg monthly or 675 mg every 3 months (as three consecutive injections of 225 mg each)
Latin Shorthand
50 mg PRN or 100 mg PNR. Severe Renal Impairment: 50mg.
225 mg/mo or 675 mg q3mo
Financial Assistance
Copay
$0
$5
Annual Cap
Maximum savings of $50 per pill for up to 13 prescription fills.
Patient specific maximum benefit.
Assistance Expiration
13 prescription fills
12/31/2023
Generics
No lower-cost generic available
No lower-cost generic available